---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-14T17:16:00.825341'
end_time: '2025-12-14T17:26:59.406064'
duration_seconds: 658.58
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: POLE4
  gene_symbol: POLE4
  uniprot_accession: Q9NR33
  protein_description: 'RecName: Full=DNA polymerase epsilon subunit 4; AltName: Full=DNA
    polymerase II subunit 4; AltName: Full=DNA polymerase epsilon subunit p12;'
  gene_info: Name=POLE4;
  organism_full: Homo sapiens (Human).
  protein_family: Not specified in UniProt
  protein_domains: CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg.
    (IPR050568); CBFD_NFYB_HMF (PF00808)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 15
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NR33
- **Protein Description:** RecName: Full=DNA polymerase epsilon subunit 4; AltName: Full=DNA polymerase II subunit 4; AltName: Full=DNA polymerase epsilon subunit p12;
- **Gene Information:** Name=POLE4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "POLE4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'POLE4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **POLE4** (gene ID: POLE4, UniProt: Q9NR33) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NR33
- **Protein Description:** RecName: Full=DNA polymerase epsilon subunit 4; AltName: Full=DNA polymerase II subunit 4; AltName: Full=DNA polymerase epsilon subunit p12;
- **Gene Information:** Name=POLE4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Not specified in UniProt
- **Key Domains:** CBFA_NFYB_domain. (IPR003958); Histone-fold. (IPR009072); Transcr_DNA_Rep_Reg. (IPR050568); CBFD_NFYB_HMF (PF00808)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "POLE4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'POLE4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **POLE4** (gene ID: POLE4, UniProt: Q9NR33) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan overview
- We verified the target identity (POLE4; UniProt Q9NR33) and matched it to the human DNA polymerase epsilon (Pol ε) accessory subunit carrying a histone-fold/CBFA_NFYB-like domain. We then gathered recent mechanistic and structural literature (prioritizing 2023–2024), classic foundational studies, and therapeutic-sensitivity screens. We synthesized function, pathways, localization, disease links, and quantitative details, and compiled a table of recent advances.

Verification of target identity and domain architecture
- Identity and organism: POLE4 encodes the fourth, small accessory subunit of human DNA polymerase ε (Pol ε), part of a four-subunit complex with the catalytic POLE1 and accessory subunits POLE2 and POLE3; the small subunits POLE3/POLE4 are orthologous to yeast Dpb3/Dpb4. These small subunits carry histone-fold motifs and form a heterodimeric module associated with Pol ε (human; Homo sapiens) (bellelli2018polεinstabilitydrives pages 1-3, bellelli2018pole3pole4isa pages 4-5).
- Domains: Biochemical mapping established that POLE3–POLE4 forms a histone-fold heterodimer that binds histone H3–H4, consistent with annotations to CBFA_NFYB/histone-fold superfamilies. Disrupting interface residues (e.g., POLE4 Phe74, POLE3 Phe44) destabilizes the dimer and Pol ε association, supporting the histone-fold and CBFA_NFYB-like domain assignments functionally (bellelli2018pole3pole4isa pages 4-5, bellelli2018pole3pole4isa pages 18-20).
- Ambiguity check: The literature cited here explicitly studies human POLE4 as a Pol ε subunit. No conflicting alternative gene/protein with the same symbol in a different organism is used in our evidence; therefore, we proceed with human POLE4 (Q9NR33).

Key concepts: molecular function, complex membership, and localization
- Complex membership and architecture: Human Pol ε comprises POLE1 (catalytic), POLE2, POLE3, and POLE4. POLE3–POLE4 forms a stable heterodimeric histone-fold module that associates with the Pol ε holoenzyme, stabilizing the complex and connecting the replisome to chromatin assembly (bellelli2018polεinstabilitydrives pages 1-3, bellelli2018pole3pole4isa pages 4-5, bellelli2018pole3pole4isa pages 1-3).
- Molecular function: POLE4, as part of the POLE3–POLE4 module, functions as an H3–H4 histone chaperone. The module binds both newly synthesized and parental H3–H4 in chromatin, promotes tetrasome formation in vitro, and supports replication-coupled nucleosome assembly and maturation during S phase. Loss of POLE3/POLE4 disrupts histone dynamics and nucleosome maturation at replication forks (bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 12-14).
- Cellular localization: POLE4 functions within the nuclear replisome at replication forks, associated with Pol ε on the leading strand; the POLE3–POLE4 module is proposed to bias parental histone H3–H4 recycling to the leading strand, complementing MCM2 on the lagging strand (bellelli2018pole3pole4isa pages 12-14).

Recent developments and latest research (prioritizing 2023–2024)
- 2024 human Pol ε–PCNA cryo-EM: He et al. solved structures of human Pol ε–PCNA–DNA in incoming-nucleotide and nucleotide-exchange states. The catalytic domain engages PCNA via a three-point interface (PIP motif, unique P-domain, and thumb contacting different PCNA protomers). The non-catalytic lobe (including POLE2–POLE3–POLE4) was not resolved, consistent with conformational flexibility in human Pol ε. Assembly conditions included 1 μM Pol ε, 3 μM PCNA, 1.2 μM primer/template; Pol ε was concentrated to 3.7 mg/mL for cryo-EM (Nature Communications; published September 2024; https://doi.org/10.1038/s41467-024-52257-x) (he2024structuresofthe pages 9-10).
- 2023 mechanistic insights into DNA damage repair coupling: Mao et al. showed that POLE3 (POLE4’s obligate dimer partner) cooperates with CHRAC1 to promote double-strand break (DSB) repair and KU80 recruitment; WDR70 regulates POLE3 expression via H2BK120ub1/H3K79me2 marks at the POLE3 locus. POLE3 loss increases camptothecin (CPT)-induced DNA damage (γH2AX, p-RPA32), indicating a chromatin-coupled repair role for the POLE3–POLE4 axis (Science Advances; September 2023; https://doi.org/10.1126/sciadv.adh2358) (mao2023requirementofwdr70 pages 8-11).
- Foundational and integrative updates: Multiple studies consistently support a model in which the POLE3–POLE4 histone-fold dimer chaperones H3–H4 at forks to maintain chromatin integrity and promote faithful histone recycling, complementing leading/lagging asymmetry observed in replication-coupled histone dynamics (bellelli2018pole3pole4isa pages 4-5, bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 12-14).

Current applications and real-world implementations
- Structural and mechanistic frameworks: The 2024 human Pol ε–PCNA cryo-EM structures inform how Pol ε engages PCNA and occludes other PIP-containing factors, shaping models of leading-strand processivity and replisome factor exchange. These structures provide a template for interpreting how the flexible non-catalytic lobe (POLE2–POLE3–POLE4) rearranges during synthesis and could be leveraged in structure-guided hypotheses of fork regulation and vulnerability (he2024structuresofthe pages 9-10).
- Therapeutic sensitivity biomarkers: Genome-scale CRISPR screening identified POLE3 and POLE4 loss as genetic vulnerabilities that confer marked hypersensitivity to ATR inhibition (e.g., AZD6738), nominating POLE3/POLE4 deficiency as a putative biomarker for ATR inhibitor response and as an entry point for synthetic-lethality strategies under replication stress (Open Biology; September 2019; https://doi.org/10.1098/rsob.190156) (hustedt2019aconsensusset pages 7-8).
- DNA damage response coupling: Experimental assays linking POLE3–CHRAC1–KU80 and WDR70-dependent chromatin signaling to DSB repair suggest actionable nodes for modulating repair capacity in cancer models with replication stress, potentially in combination with topoisomerase poisons (e.g., CPT) or checkpoint inhibitors (mao2023requirementofwdr70 pages 8-11).

Expert opinions and analysis from authoritative sources
- Bellelli et al. (Molecular Cell, 2018) established POLE3–POLE4 as an intrinsic H3–H4 histone chaperone within Pol ε, bridging DNA synthesis to chromatin assembly. They proposed strand-biased parental histone recycling with POLE3–POLE4 acting on the leading strand, a view supported by subsequent chromatin inheritance literature (bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 12-14).
- He et al. (Nature Communications, 2024) interpret the absence of density for the non-catalytic lobe in human Pol ε–PCNA structures as evidence of flexibility, implying transient or dynamic association of POLE2–POLE3–POLE4 relative to the catalytically engaged Pol ε core at PCNA. This contrasts with more rigid architectures described in yeast and informs expert discussions of human replisome plasticity (he2024structuresofthe pages 9-10).
- Hustedt et al. (Open Biology, 2019) argued that ATR inhibitor hypersensitivity in POLE3−/− or POLE4−/− cells is more consistent with a defect in DNA synthesis rather than a global failure of histone deposition, refining interpretations of how the POLE3–POLE4 module safeguards replication (hustedt2019aconsensusset pages 7-8).

Relevant statistics and quantitative data
- Structural parameters: human Pol ε–PCNA–DNA assembled at 1 μM Pol ε + 3 μM PCNA + 1.2 μM primer/template; Pol ε concentration for EM at 3.7 mg/mL; two states visualized (incoming nucleotide-bound and nucleotide-exchange), showing a three-point Pol ε–PCNA interface (he2024structuresofthe pages 9-10).
- Biochemistry of histone binding: The POLE3–POLE4 dimer robustly binds H3–H4 in a salt-dependent manner in vitro (binding strong at ~150 mM NaCl; reduced by ~50% at 300 mM; near-loss at 500 mM), supporting specific histone chaperone activity and multiple interaction surfaces on each subunit (bellelli2018pole3pole4isa pages 4-5).
- Genetic screening: POLE3/POLE4 were among a curated set of 117 genes conferring ATR inhibitor sensitivity in genome-scale CRISPR screens; clonogenic validations used AZD6738 (hustedt2019aconsensusset pages 7-8).
- DNA damage assays: POLE3 knockdown increased CPT-induced DNA damage within 4–12 h (γH2AX and p-RPA32 foci; comet assays), and impaired DSB repair readouts (HR/NHEJ reporters). A cancer-relevant CHRAC1 D121Y mutant failed to rescue repair defects due to weakened interaction with POLE3 (mao2023requirementofwdr70 pages 8-11).

Disease and phenotype associations
- Replication stress and development: Pol ε instability due to loss of POLE4 (and reduced Pol ε levels) drives replication stress, p53 activation, growth and developmental defects in mice, and tumor predisposition. Similar cellular phenotypes occur in human cells bearing destabilizing POLE1 mutations, linking Pol ε hypomorphy to human developmental disease spectra with microcephaly and growth restriction features (Molecular Cell, 2018; https://doi.org/10.1016/j.molcel.2018.04.008) (bellelli2018polεinstabilitydrives pages 1-3).
- Chromatin inheritance defects: Perturbing POLE3/POLE4 disrupts histone recycling and nucleosome maturation at forks, a mechanism plausibly underlying aspects of microcephaly/growth phenotypes observed in Pol ε deficiency models (bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 12-14).
- Cancer relevance: Pol ε instability promotes tumorigenesis in mouse models; DNA repair coupling via POLE3–CHRAC1 and chromatin signaling via WDR70 at the POLE3 locus underscore potential mutational and epigenetic routes to genome instability in human cancers (bellelli2018polεinstabilitydrives pages 1-3, mao2023requirementofwdr70 pages 8-11).

Primary function distilled
- POLE4 is a small, non-catalytic Pol ε subunit that, together with POLE3, forms a histone-fold heterodimer acting as an H3–H4 histone chaperone at the leading-strand replisome. It stabilizes Pol ε, facilitates parental histone recycling and new histone deposition, and contributes to genome and epigenome integrity during S phase. The catalytic polymerase activity resides in POLE1; POLE4 does not catalyze nucleotide addition but enables chromatin-coupled replication (bellelli2018polεinstabilitydrives pages 1-3, bellelli2018pole3pole4isa pages 4-5, bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 12-14).

Recent POLE4-related advances (compact table)
| Year | Study (first author) | System / Method | Key finding about POLE4 / POLE3–POLE4 or Pol ε | Quantitative detail | Journal | URL |
|------|----------------------|------------------|-------------------------------------------------|--------------------|---------|-----|
| 2024 | He (he2024structuresofthe pages 9-10) | Human Pol ε–PCNA–DNA cryo-EM; in vitro assembly (biochemistry + cryo-EM) | Human Pol ε–PCNA structure shows a flexible non-catalytic lobe; POLE3/POLE4 density not resolved; catalytic domain engages PCNA via a 3‑point interface (PIP, P‑domain, thumb). | Pol ε concentrated to 3.7 mg/mL; assembly: 1 μM Pol ε + 3 μM PCNA + 1.2 μM primer/template; two cryo-EM states reported (incoming nucleotide and nucleotide-exchange). | Nature Communications (2024) | https://doi.org/10.1038/s41467-024-52257-x (he2024structuresofthe pages 9-10) |
| 2023 | Mao (mao2023requirementofwdr70 pages 8-11) | Cell-based assays (HCT116/HT29), co-IP, ChIP, laser microirradiation, CPT treatment | POLE3 (partner of POLE4) promotes DSB repair via interaction with CHRAC1 and recruitment of KU80; WDR70 regulates POLE3 expression through chromatin marks; POLE3 loss increases CPT-induced DNA damage. | CPT treatment (4–12 h) produced increased γH2AX and p‑RPA32 foci in shPOLE3 cells; CHRAC1 D121Y fails to rescue repair phenotypes. | Science Advances (2023) | https://doi.org/10.1126/sciadv.adh2358 (mao2023requirementofwdr70 pages 8-11) |
| 2023 | Ahmad () | Genetic cell models (POLE1 exonuclease mutant, CTF18−/−, PARP1−/−), drug sensitivity assays | Pol ε exonuclease and CTF18 promote tolerance to camptothecin (CPT); PARP1 is required for this tolerance, linking Pol ε exonuclease activity to fork stability and drug response. | POLE1exo−/− cells show CPT sensitivity comparable to BRCA1−/−; combining POLE1exo−/− with BRCA1−/− synergistically increases CPT sensitivity. | Nucleic Acids Research (2023) | https://doi.org/10.1093/nar/gkad999 () |
| 2019 | Hustedt (hustedt2019aconsensusset pages 7-8) | Genome-scale CRISPR screens for ATR inhibitor (AZD6738) vulnerabilities; clonogenic assays | Loss of POLE3 or POLE4 causes marked hypersensitivity to ATR inhibition (AZD6738), implicating POLE3/POLE4 in replication-associated processes required for ATR inhibitor tolerance. | Identified within a consensus set of 117 genes whose loss confers ATRi sensitivity; POLE3/POLE4 among validated hypersensitivity hits using AZD6738. | Open Biology (2019) | https://doi.org/10.1098/rsob.190156 (hustedt2019aconsensusset pages 7-8) |


*Table: Compact summary table of key 2019–2024 studies linking POLE4/POLE3–POLE4 to Pol ε structure, parental histone/chromatin roles, DNA repair and therapeutic sensitivities (ATRi/PARPi/CPT); includes methods, quantitative details and provenance for quick reference.*

Citations (URLs and dates)
- He Q, Wang F, Yao NY, O’Donnell ME, Li H. Structures of the human leading strand Pol ε–PCNA holoenzyme. Nature Communications. 2024-09. https://doi.org/10.1038/s41467-024-52257-x (he2024structuresofthe pages 9-10).
- Mao X, Wu J, Zhang Q, et al. Requirement of WDR70 for POLE3-mediated DNA double-strand breaks repair. Science Advances. 2023-09. https://doi.org/10.1126/sciadv.adh2358 (mao2023requirementofwdr70 pages 8-11).
- Bellelli R, Belan O, Pye VE, et al. POLE3–POLE4 is a histone H3–H4 chaperone that maintains chromatin integrity during DNA replication. Molecular Cell. 2018-10. https://doi.org/10.1016/j.molcel.2018.08.043 (bellelli2018pole3pole4isa pages 4-5, bellelli2018pole3pole4isa pages 1-3, bellelli2018pole3pole4isa pages 18-20, bellelli2018pole3pole4isa pages 12-14).
- Bellelli R, Borel V, Logan C, et al. Pol ε instability drives replication stress, abnormal development, and tumorigenesis. Molecular Cell. 2018-05. https://doi.org/10.1016/j.molcel.2018.04.008 (bellelli2018polεinstabilitydrives pages 1-3).
- Hustedt N, Álvarez-Quilón A, McEwan A, et al. A consensus set of genetic vulnerabilities to ATR inhibition. Open Biology. 2019-09. https://doi.org/10.1098/rsob.190156 (hustedt2019aconsensusset pages 7-8).
- Zakharenko AL, Malakhova AA, Dyrkheeva NS, et al. PARP1 Gene Knockout Suppresses Expression of DNA Base Excision Repair Genes. Doklady Biochemistry and Biophysics. 2023-01. https://doi.org/10.1134/S1607672922700028 (zakharenko2023parp1geneknockout pages 6-6).

Notes and open questions
- The 2024 human Pol ε–PCNA structures do not resolve the non-catalytic lobe (POLE2–POLE3–POLE4), highlighting a current frontier: capturing POLE3–POLE4 placement relative to PCNA and DNA in human holoenzyme states. This will refine mechanistic models of how histone chaperoning is physically coupled to synthesis in the human replisome (he2024structuresofthe pages 9-10).

References

1. (bellelli2018polεinstabilitydrives pages 1-3): Roberto Bellelli, Valerie Borel, Clare Logan, Jennifer Svendsen, Danielle E. Cox, Emma Nye, Kay Metcalfe, Susan M. O’Connell, Gordon Stamp, Helen R. Flynn, Ambrosius P. Snijders, François Lassailly, Andrew Jackson, and Simon J. Boulton. Polε instability drives replication stress, abnormal development, and tumorigenesis. Molecular Cell, 70:707-721.e7, May 2018. URL: https://doi.org/10.1016/j.molcel.2018.04.008, doi:10.1016/j.molcel.2018.04.008. This article has 88 citations and is from a highest quality peer-reviewed journal.

2. (bellelli2018pole3pole4isa pages 4-5): Roberto Bellelli, Ondrej Belan, Valerie E. Pye, Camille Clement, Sarah L. Maslen, J. Mark Skehel, Peter Cherepanov, Genevieve Almouzni, and Simon J. Boulton. Pole3-pole4 is a histone h3-h4 chaperone that maintains chromatin integrity during dna replication. Molecular Cell, 72:112-126.e5, Oct 2018. URL: https://doi.org/10.1016/j.molcel.2018.08.043, doi:10.1016/j.molcel.2018.08.043. This article has 135 citations and is from a highest quality peer-reviewed journal.

3. (bellelli2018pole3pole4isa pages 18-20): Roberto Bellelli, Ondrej Belan, Valerie E. Pye, Camille Clement, Sarah L. Maslen, J. Mark Skehel, Peter Cherepanov, Genevieve Almouzni, and Simon J. Boulton. Pole3-pole4 is a histone h3-h4 chaperone that maintains chromatin integrity during dna replication. Molecular Cell, 72:112-126.e5, Oct 2018. URL: https://doi.org/10.1016/j.molcel.2018.08.043, doi:10.1016/j.molcel.2018.08.043. This article has 135 citations and is from a highest quality peer-reviewed journal.

4. (bellelli2018pole3pole4isa pages 1-3): Roberto Bellelli, Ondrej Belan, Valerie E. Pye, Camille Clement, Sarah L. Maslen, J. Mark Skehel, Peter Cherepanov, Genevieve Almouzni, and Simon J. Boulton. Pole3-pole4 is a histone h3-h4 chaperone that maintains chromatin integrity during dna replication. Molecular Cell, 72:112-126.e5, Oct 2018. URL: https://doi.org/10.1016/j.molcel.2018.08.043, doi:10.1016/j.molcel.2018.08.043. This article has 135 citations and is from a highest quality peer-reviewed journal.

5. (bellelli2018pole3pole4isa pages 12-14): Roberto Bellelli, Ondrej Belan, Valerie E. Pye, Camille Clement, Sarah L. Maslen, J. Mark Skehel, Peter Cherepanov, Genevieve Almouzni, and Simon J. Boulton. Pole3-pole4 is a histone h3-h4 chaperone that maintains chromatin integrity during dna replication. Molecular Cell, 72:112-126.e5, Oct 2018. URL: https://doi.org/10.1016/j.molcel.2018.08.043, doi:10.1016/j.molcel.2018.08.043. This article has 135 citations and is from a highest quality peer-reviewed journal.

6. (he2024structuresofthe pages 9-10): Qing He, Feng Wang, Nina Y. Yao, Michael E. O’Donnell, and Huilin Li. Structures of the human leading strand polε–pcna holoenzyme. Nature Communications, Sep 2024. URL: https://doi.org/10.1038/s41467-024-52257-x, doi:10.1038/s41467-024-52257-x. This article has 12 citations and is from a highest quality peer-reviewed journal.

7. (mao2023requirementofwdr70 pages 8-11): Xiaobing Mao, Jian Wu, Qin Zhang, Su Zhang, Xiaoshuang Chen, Xueqin Liu, Mingtian Wei, Xiaowen Wan, Lei Qiu, Ming Zeng, Xue Lei, Cong Liu, and Junhong Han. Requirement of wdr70 for pole3-mediated dna double-strand breaks repair. Science Advances, Sep 2023. URL: https://doi.org/10.1126/sciadv.adh2358, doi:10.1126/sciadv.adh2358. This article has 11 citations and is from a highest quality peer-reviewed journal.

8. (hustedt2019aconsensusset pages 7-8): Nicole Hustedt, Alejandro Álvarez-Quilón, Andrea McEwan, Jing Yi Yuan, Tiffany Cho, Lisa Koob, Traver Hart, and Daniel Durocher. A consensus set of genetic vulnerabilities to atr inhibition. Open Biology, 9:190156, Sep 2019. URL: https://doi.org/10.1098/rsob.190156, doi:10.1098/rsob.190156. This article has 116 citations and is from a peer-reviewed journal.

9. (zakharenko2023parp1geneknockout pages 6-6): A. L. Zakharenko, A. A. Malakhova, N. S. Dyrkheeva, L. S. Okorokova, S. P. Medvedev, S. M. Zakian, M. R. Kabilov, A. A. Tupikin, and O. I. Lavrik. Parp1 gene knockout suppresses expression of dna base excision repair genes. Doklady. Biochemistry and Biophysics, 508:6-11, Jan 2023. URL: https://doi.org/10.1134/s1607672922700028, doi:10.1134/s1607672922700028. This article has 3 citations.

## Citations

1. he2024structuresofthe pages 9-10
2. hustedt2019aconsensusset pages 7-8
3. https://doi.org/10.1038/s41467-024-52257-x
4. https://doi.org/10.1126/sciadv.adh2358
5. https://doi.org/10.1098/rsob.190156
6. https://doi.org/10.1016/j.molcel.2018.04.008
7. https://doi.org/10.1093/nar/gkad999
8. https://doi.org/10.1016/j.molcel.2018.08.043
9. https://doi.org/10.1134/S1607672922700028
10. https://doi.org/10.1016/j.molcel.2018.04.008,
11. https://doi.org/10.1016/j.molcel.2018.08.043,
12. https://doi.org/10.1038/s41467-024-52257-x,
13. https://doi.org/10.1126/sciadv.adh2358,
14. https://doi.org/10.1098/rsob.190156,
15. https://doi.org/10.1134/s1607672922700028,